With industry-leading variant classification, personalized risk insights, and streamlined workflows, the MyRisk® Hereditary Cancer Test with RiskScore® supports your efforts in breast cancer risk assessment, early detection and treatment.
From easy ordering within your EMR to patient education and clinical decision-making, Myriad Oncology™ provides the tools and insights you need to deliver confident, proactive care—every step of the way.
Download MyRisk Test product details and start revealing hidden breast cancer risk for more patients.
©2025 Myriad Genetics, Myriad Oncology MyRisk, RiskScore, and their respective logos, are either trademarks or registered trademarks of Myriad Genetics, Inc. and its subsidiaries in the United States and other jurisdictions.